15-PGDH expression is lost in the majority of colorectal adenocarcinomas, and this loss is associated with altered prostaglandin levels and poor prognosis12–14, indicating that re-establishment of 15-PGDH expression may provide a therapeutic benefit. Here, HPGD is linked to colorectal adenocarcinoma.